
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy
Reece, DE, Barnett, MJ, Shepherd, JD, Hogge, DE, Klasa, RJ, Nantel, SH, Sutherland, HJ, Klingemann, HG, Fairey, RN, Voss, NJVolume:
86
Journal:
Blood
DOI:
10.1182/blood.v86.2.451.bloodjournal862451
Date:
July, 1995
Fichier:
PDF, 694 KB
1995